Event JSON
{
"id": "a8a384b48c20d4a0bbc05e8b2c921a20e64c526f145532defb32ddce50d0f94e",
"pubkey": "dcc7000c7d9a2ff0c6caab5455aef359c597d85cf2388303badbb8ac88c2d2bc",
"created_at": 1737996953,
"kind": 1,
"tags": [
[
"r",
"https://www.rt.com/russia/611731-gamaleya-cancer-vaccine-date/?utm_source=rss\u0026utm_medium=rss\u0026utm_campaign=RSS"
],
[
"subject",
"Russian lab touts MRNA cancer vaccine by end of year"
],
[
"published_at",
"1737996948"
],
[
"image",
"https://mf.b37mrtl.ru/files/2025.01/thumbnail/6797b8382030275d147fac63.jpg"
],
[
"p",
"dcc7000c7d9a2ff0c6caab5455aef359c597d85cf2388303badbb8ac88c2d2bc",
"wss://relay-testnet.k8s.layer3.news"
],
[
"imeta",
"url https://mf.b37mrtl.ru/files/2025.01/thumbnail/6797b8382030275d147fac63.jpg"
],
[
"t",
"eastern-bloc:perspective"
],
[
"summary",
"The vaccine, developed using mRNA technology, is a therapeutic vaccine designed to be administered to those already diagnosed with cancer. It causes the patient's immune system to start destroying malignant cells. The vaccine is tailor-made for each patient and developed with the help of artificial intelligence, which analyzes the parameters of the tumor and issues a 'blueprint' for the drug."
]
],
"content": "nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgxucuqqclv69lcvdj4t2326au6ecktash8j8zps8wkmhzkg3skjhsumr32m\nhttps://mf.b37mrtl.ru/files/2025.01/thumbnail/6797b8382030275d147fac63.jpg\nRussia’s cancer vaccine could receive approval by August, allowing treatment to begin, the head of the Gamaleya Research Institute has said Read Full Article at RT.com\nhttps://www.rt.com/russia/611731-gamaleya-cancer-vaccine-date/?utm_source=rss\u0026utm_medium=rss\u0026utm_campaign=RSS",
"sig": "80ffb81f224745c318ab9daa6c98dbd041352abfc7624be41ad9fc4423bdd60eadac79f958f3cc4d51f980b7d93ba14cdd4e8d9fde5b18502c766984ae5f0e8a"
}
